Why is Gian Lifecare falling/rising?

As of 11-Sep, Gian Lifecare Ltd's stock is currently priced at 16.18, reflecting an increase of 0.48 or 3.06%. The stock has been on a positive trajectory, gaining for the last seven days with a total return of 15.57% during this period. It has outperformed its sector by 3.58% today, and the delivery volume has seen a significant rise of 132.45% compared to the 5-day average, indicating increased investor participation. However, despite this recent uptick, the stock has underperformed over longer periods, with a 1-month return of -6.26% and a year-to-date decline of -13.94%. The company faces challenges, including weak long-term fundamental strength, as evidenced by a -67.01% CAGR growth in operating profits over the last five years and a return on equity of -0.2, which suggests an expensive valuation relative to its peers.
In the broader market context, Gian Lifecare's recent performance contrasts sharply with the benchmark, as it has outperformed the Sensex by a notable margin of 12.12% over the past week. However, the stock has consistently underperformed against the benchmark over the last three years, generating a return of -28.34% compared to the Sensex's minimal growth of 0.03% in the same timeframe. The high percentage of pledged promoter shares, currently at 61.17%, adds to the stock's vulnerability, particularly in a declining market, which could exert additional downward pressure on its price. Overall, while the stock is experiencing a short-term rise, its long-term outlook remains concerning due to fundamental weaknesses and historical underperformance.